Stockpolly
Search
Delisting risk
ICCM · NASDAQ · Medical - Devices

IceCure Medical (ICCM)

Liquid-nitrogen cryoablation systems and disposable probes for minimally invasive tumor treatment.

$2.28
Pre-market+0.02 (+1.02%)
At close$2.26(−0.88%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue011111111111
Cost of revenue010000101111
Gross profit010100000100
444455441855−4
Research & development222222222222
222233222323
Selling & marketing1−211221−11−211
General & administrative141111131511
Other expenses000000001400−9
Operating income−4−3−4−3−4−5−4−3−18−4−44
000000001400−9
Interest income000000000000
Interest expense000000000000
Other non-operating income00000000−14009
Income before tax−4−3−4−3−4−4−4−3−4−4−4−5
Net income from continuing operations−4−3−4−3−4−4−4−3−4−4−4−5
Net income−4−3−4−3−4−4−4−3−4−4−4−5
EPS, basic−$0.09−$2.07−$2.27−$1.88−$2.38−$2.42−$1.87−$1.72−$1.77−$1.75−$1.74−$1.46
EPS, diluted−$0.09−$2.07−$2.27−$1.88−$2.38−$2.42−$1.87−$1.72−$1.81−$1.75−$1.74−$1.46
Weighted average shares, basic4622222222223
Weighted average shares, diluted4622222222223
EBITDA−4−3−4−3−4−4−4−3−4−4−4−4
Depreciation & amortization000000000000
EBIT−4−3−4−3−4−5−4−3−4−4−4−4